# IAMGOLD

Type: Company (IAG)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/iamgold
Canonical HTML page: https://getbiobrief.com/entity/iamgold

## Recent coverage (1 stories)

### MedTech Resilience: Insulet and AtriCure Outperform Q4 Earnings Expectations
2026-02-18 19:19:07 · Sentiment: Positive · Impact: 6/10 · Sources: 6

Insulet and AtriCure reported strong quarterly results, both beating analyst estimates on top and bottom lines. These results highlight robust demand for insulin delivery systems and atrial fibrillation treatments despite broader macroeconomic pressures.
Full story: https://getbiobrief.com/story/medtech-earnings-insulet-atricure-q4-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.